NCT01492192 2017-11-01
RGD-PET-CT in Cancer Angiogenesis
Oxford University Hospitals NHS Trust
Phase 2 Terminated
Clinical Trials
3 trialsNCT01961583 2016-03-01
[18F]Fluciclatide PET Imaging of Pazopanib Response
Asan Medical Center
Phase 2 Terminated
NCT02193672 2014-07-18
A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy
M.D. Anderson Cancer Center
Phase 1 Withdrawn